Want to see VSEE full AI Analyst Report?
VSEE Stock Chart & Stats
$0.08
>-$0.01(-1.27%)
At close: 4:00 PM EDT
$0.08
>-$0.01(-1.27%)
Day’s Range― - ―
52-Week Range$0.07 - $2.52
Previous Close$0.08
Volume3.12M
Average Volume (3M)1.90M
Market Cap
$4.38M
Enterprise Value$2.78M
Total Cash (Recent Filing)$1.35M
Total Debt (Recent Filing)$2.14M
Price to Earnings (P/E)―
Beta0.43
Next Earnings
Sep 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.54
Shares Outstanding55,679,813
10 Day Avg. Volume5,577,105
30 Day Avg. Volume1,899,699
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.38
Price to Sales (P/S)0.52
P/FCF Ratio-2.17
Enterprise Value/Market Cap0.63
Enterprise Value/Revenue0.19
Enterprise Value/Gross Profit0.42
Enterprise Value/Ebitda-0.32
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.24
Revenue Forecast (FY)$21.60M
Bulls Say, Bears Say
Bulls Say
Prior Revenue Growth MomentumThe company demonstrated meaningful top-line traction in 2024–2025, indicating product-market fit for its telehealth and RPM offerings. Historical growth provides a foundation to scale recurring subscription and RPM revenues if investment and go-to-market execution continue, supporting multi-month recovery potential.
Improved Leverage And Manageable DebtLeverage has materially improved versus prior periods, with lower total debt and a reduced debt-to-equity ratio. This stronger balance-sheet posture increases financial flexibility, reduces immediate default risk, and gives the company runway to pursue strategic options such as targeted investments or M&A over the next several months.
Potential Accretive Strategic AcquisitionThe contemplated acquisition targets a profitable commerce platform that complements VSee's API-driven virtual care stack, potentially adding meaningful recurring revenue, higher EBITDA margins, and provider-facing sales capability. If executed and integrated, this would materially broaden offerings and strengthen competitive positioning long term.
Bears Say
Large Ongoing Cash Burn And LossesSustained negative operating and free cash flow reflect structural unprofitability at current scale, consuming liquidity and forcing dependence on external capital. Continued cash burn limits investments in product, sales, and integration of strategic acquisitions and raises solvency risk absent durable margin improvement or consistent new cash inflows.
Reliance On Dilutive, High-cost FinancingRepeated use of discounted convertible notes and structured financings creates prospective equity dilution, gives investors priority claims on future proceeds, and can impose restrictive cash-flow mechanics. Over months this financing mix may constrain strategic choices and erode existing shareholders' long-term economic interests.
Leadership And Structural Transition RisksThe recent divestiture and executive consolidation remove a subsidiary and change senior leadership, which can disrupt operations, concentrate decision-making, and transfer legacy liabilities to the parent. Such transitions raise execution risk for integration, strategy continuity, and near-term operational stability over the coming months.
VSee Health News
VSEE FAQ
What was VSee Health’s price range in the past 12 months?
VSee Health lowest stock price was $0.07 and its highest was $2.52 in the past 12 months.
What is VSee Health’s market cap?
VSee Health’s market cap is $4.38M.
When is VSee Health’s upcoming earnings report date?
VSee Health’s upcoming earnings report date is Sep 28, 2026 which is in 57 days.
How were VSee Health’s earnings last quarter?
Currently, no data Available
Is VSee Health overvalued?
According to Wall Street analysts VSee Health’s price is currently Overvalued.
Does VSee Health pay dividends?
VSee Health does not currently pay dividends.
What is VSee Health’s EPS estimate?
VSee Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VSee Health have?
VSee Health has 55,679,813 shares outstanding.
What happened to VSee Health’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of VSee Health?
Currently, no hedge funds are holding shares in VSEE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
VSee Health
VSee Health, Inc. specializes in delivering virtual healthcare solutions. Their flagship offering, iDoc Telehealth, is specifically designed to manage and coordinate comprehensive care for severely ill individuals within various critical care environments, including neurointensive, cardiac intensive, and general intensive care units (ICUs). This system addresses complex conditions such as stroke, spinal cord injuries, brain trauma, and other severe neurological disorders. Beyond specialized care, their broader telehealth platform provides a modular suite of digital tools, empowering clients to customize solutions to their unique needs. VSee Health, Inc. is headquartered in Newton, Massachusetts.
Technical Analysis
Ownership Overview
9.89% Insiders
0.50% Mutual Funds
0.03% Other Institutional Investors
89.19% Public Companies and
Individual Investors